Close
Achema

Articles

Drug-Eluting Devices: Delivering on Drug Delivery’s Combined Potential

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel. Over their development history,...

A Powerful Pairing: Academia-Industry Collaborations for Pharmaceutical Innovation

Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not extend...

Top Three Considerations for Purchasing Antibodies

Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states. These tools, with their high specificity...

Steps to Compliance: How Best to Prepare for Russia’s...

Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or...

Data Collection in Phase II-III Clinical Research – It...

Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data...

Why AI in Drug Discovery has Yet to Live...

Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted. Despite...

First step to Secondary Packaging: Start with the End...

No matter if it is meeting the needs of a rapidly aging market, blocking drug counterfeiters or differentiating your pharmaceutical product in the market, a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read